Preventing Cardiotoxicity Associated With Breast Cancer Therapy
An angiotensin-converting enzyme (ACE) inhibitor and β-blocker prevented cardiotoxicity associated with combination chemotherapy in women with ERBB2 (formerly HER2)–positive breast cancer, reported a trial in the Journal of the American College of Cardiology.
Source: JAMA - Category: General Medicine Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Cancer Therapy | Cardiology | Chemotherapy | General Medicine | Heart | HER2 | Women